Suppr超能文献

优化人眼角膜内皮细胞功能的细胞培养方法。

A Cell Culture Approach to Optimized Human Corneal Endothelial Cell Function.

机构信息

Shiley Eye Institute, University of California San Diego, La Jolla, California, United States.

Byers Eye Institute and Spencer Center for Vision Research, Department of Ophthalmology, Stanford University, Palo Alto, California, United States.

出版信息

Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1617-1629. doi: 10.1167/iovs.17-23637.

Abstract

PURPOSE

Cell-based therapies to replace corneal endothelium depend on culture methods to optimize human corneal endothelial cell (HCEC) function and minimize endothelial-mesenchymal transition (EnMT). Here we explore contribution of low-mitogenic media on stabilization of phenotypes in vitro that mimic those of HCECs in vivo.

METHODS

HCECs were isolated from cadaveric donor corneas and expanded in vitro, comparing continuous presence of exogenous growth factors ("proliferative media") to media without those factors ("stabilizing media"). Identity based on canonical morphology and expression of surface marker CD56, and function based on formation of tight junction barriers measured by trans-endothelial electrical resistance assays (TEER) were assessed.

RESULTS

Primary HCECs cultured in proliferative media underwent EnMT after three to four passages, becoming increasingly fibroblastic. Stabilizing the cells before each passage by switching them to a media low in mitogenic growth factors and serum preserved canonical morphology and yielded a higher number of cells. HCECs cultured in stabilizing media increased both expression of the identity marker CD56 and also tight junction monolayer integrity compared to cells cultured without stabilization.

CONCLUSIONS

HCECs isolated from donor corneas and expanded in vitro with a low-mitogenic media stabilizing step before each passage demonstrate more canonical structural and functional features and defer EnMT, increasing the number of passages and total canonical cell yield. This approach may facilitate development of HCEC-based cell therapies.

摘要

目的

用于替代角膜内皮的细胞疗法依赖于培养方法,以优化人角膜内皮细胞(HCEC)的功能并最大程度减少内皮-间充质转化(EnMT)。在此,我们探索了低有丝分裂培养基对体外表型稳定的贡献,这些表型模拟了体内 HCEC 的表型。

方法

从尸体供体角膜中分离出 HCEC 并进行体外扩增,比较外源性生长因子持续存在(“增殖培养基”)与无这些因子的培养基(“稳定培养基”)对细胞的影响。通过跨内皮电阻(TEER)测定来评估基于表面标志物 CD56 的表达和功能的鉴定,以及基于紧密连接屏障形成的功能鉴定。

结果

在增殖培养基中培养的原代 HCEC 在经过三到四代传代后发生 EnMT,逐渐呈现成纤维细胞样。在每次传代前通过切换到生长因子和血清含量低的培养基来稳定细胞,可以保留经典形态并获得更多的细胞。与未进行稳定化培养的细胞相比,在稳定培养基中培养的 HCEC 表达身份标志物 CD56 的能力增强,且紧密连接单层完整性也得到增强。

结论

从供体角膜中分离出的 HCEC,并在每次传代前使用低有丝分裂培养基进行稳定化培养,可以显示出更多的经典结构和功能特征,并延缓 EnMT 的发生,增加传代次数和总细胞产量。这种方法可能有助于开发基于 HCEC 的细胞疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f9d/5869002/3dc717d83a3d/i1552-5783-59-3-1617-f01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验